Bayer gets warning; Dey loses drugs

> The FDA has expressed concern to Bayer about the testing and quality of pharmaceutical ingredients made at a German facility. Article

> Mylan subsidiary Dey has issued an advisory regarding the theft of two respiratory medications after a tractor-trailer was stolen in Florida. Release

> Drug delivery company OctoPlus will perform process development and clinical manufacturing of Axentis Pharma's lead product, an inhalable treatment for cystic fibrosis. Release

> Ulm, Germany, will host the European Innovation Showcase, an event featuring details of award-winning pharmaceutical manufacturing facilities, in November. Release

> Eli Lilly is creating a Development Center of Excellence to streamline and accelerate late-stage drug development, and says it will reorganize its pharmaceutical business and "significantly reduce" its cost structure by the 2011. Article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.